Another experiment was performed to examine the human breast cancer cell lines having different levels of expression of neu/HER2 and to establish that apigenin exhibited potent growth-inhibitory activity in HER2/neu-overexpressing breast cancer cells. Here, ERBB2 is linked to breast cancer.